Biotage AB (BIOT) - Total Liabilities

Latest as of March 2025: Skr862.00 Million SEK ≈ $92.76 Million USD

Based on the latest financial reports, Biotage AB (BIOT) has total liabilities worth Skr862.00 Million SEK (≈ $92.76 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Biotage AB's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Biotage AB - Total Liabilities Trend (2000–2024)

This chart illustrates how Biotage AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Biotage AB asset portfolio.

Biotage AB Competitors by Total Liabilities

The table below lists competitors of Biotage AB ranked by their total liabilities.

Company	Country	Total Liabilities
OCI Co Ltd KO:010060	Korea	₩3.30 Trillion
Xiamen Solex High-Tech Industries Co Ltd SHG:603992	China	CN¥1.12 Billion
Treehouse Foods Inc NYSE:THS	USA	$2.51 Billion
Herbalife Nutrition Ltd NYSE:HLF	USA	$3.30 Billion
Hoymiles Power Electronics Inc SHG:688032	China	CN¥1.94 Billion
Grupo Televisa S.A.B. F:TLV	Germany	€122.08 Billion
Beijing Urban Construction Investment & Development Co Ltd SHG:600266	China	CN¥78.25 Billion
Koh Young Technology Inc KQ:098460	Korea	₩94.77 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down Biotage AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Biotage AB to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.88	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotage AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotage AB (2000–2024)

The table below shows the annual total liabilities of Biotage AB from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr991.00 Million ≈ $106.65 Million	-22.21%
2023-12-31	Skr1.27 Billion ≈ $137.10 Million	+81.48%
2022-12-31	Skr702.00 Million ≈ $75.55 Million	+13.23%
2021-12-31	Skr620.00 Million ≈ $66.72 Million	+39.51%
2020-12-31	Skr444.40 Million ≈ $47.82 Million	-3.43%
2019-12-31	Skr460.19 Million ≈ $49.52 Million	+52.87%
2018-12-31	Skr301.02 Million ≈ $32.39 Million	+102.59%
2017-12-31	Skr148.59 Million ≈ $15.99 Million	+12.60%
2016-12-31	Skr131.96 Million ≈ $14.20 Million	+8.01%
2015-12-31	Skr122.17 Million ≈ $13.15 Million	+5.00%
2014-12-31	Skr116.36 Million ≈ $12.52 Million	+0.77%
2013-12-31	Skr115.47 Million ≈ $12.43 Million	-6.30%
2012-12-31	Skr123.24 Million ≈ $13.26 Million	-8.81%
2011-12-31	Skr135.16 Million ≈ $14.55 Million	+7.71%
2010-12-31	Skr125.48 Million ≈ $13.50 Million	-9.31%
2009-12-31	Skr138.36 Million ≈ $14.89 Million	-20.58%
2008-12-31	Skr174.22 Million ≈ $18.75 Million	-9.42%
2007-12-31	Skr192.33 Million ≈ $20.70 Million	-6.08%
2006-12-31	Skr204.79 Million ≈ $22.04 Million	-13.40%
2005-12-31	Skr236.49 Million ≈ $25.45 Million	+37.47%
2004-12-31	Skr172.03 Million ≈ $18.51 Million	-20.78%
2003-12-31	Skr217.15 Million ≈ $23.37 Million	+250.96%
2002-12-31	Skr61.88 Million ≈ $6.66 Million	+0.07%
2001-12-31	Skr61.83 Million ≈ $6.65 Million	+20.98%
2000-12-31	Skr51.11 Million ≈ $5.50 Million	--

About Biotage AB

ST:BIOT Sweden Medical Instruments & Supplies

Market Cap

$1.23 Billion

Skr11.46 Billion SEK

Market Cap Rank

#7993 Global

#122 in Sweden

Share Price

Skr143.20

Change (1 day)

+0.00%

52-Week Range

Skr143.20 - Skr143.20

All Time High

Skr280.87